The potential of dark tea in cancer prevention and management.
FDA adcomm votes in favor of Ipsen’s fibrodysplasia drug
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted in support of the efficacy and risk-benefit profile of Ipsen Biopharmaceuticals’ drug palovarotene, which the agency